Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-098992
Filing Date
2010-04-29
Accepted
2010-04-29 14:29:47
Documents
3
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 218771
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6502
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6356
  Complete submission text file 0001193125-10-098992.txt   233160
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52228 | Film No.: 10780859
SIC: 6770 Blank Checks